| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/10/2008 | US20080085305 Robust sustained release formulations of oxymorphone |
| 04/10/2008 | US20080085304 Robust sustained release formulations |
| 04/10/2008 | US20080085303 Administering 5-80 mg of a single dose with 200-300 ml of 4-40% ethanol to provide a secondary peak of blood drug concentration about 12 hours later along with providing pain relief; solid dosage containing hydrophilic gum particles of #270 mesh size; alcoholic beverage-resistant; no dose dumping |
| 04/10/2008 | US20080085302 Administering a time-dependent antimicrobial drug transdermally to achieve a serum concentration that remains above the minimum inhibitory concentration (MIC) of the drug consistantly to reduce risk of drug resistance and gastrointstinal side effects; zero order kinetics; shortened therapy duration |
| 04/10/2008 | US20080085301 Method for transdermal administration of antimicrobial medications |
| 04/10/2008 | US20080085299 Peptides derived from colostrinin |
| 04/10/2008 | US20080085298 administering insulin, a dissolution agent and a zinc chelator to a mucosal surface, preferably the mouth or under the tongue; enhanced uptake and transport through epithelial cells as compared to insulin alone or with a zinc chelator and hydrochloric acid in a gel, film, powder or patch; stability |
| 04/10/2008 | US20080085295 Hydrogels containing low molecular weight alginates and biostructures made therefrom |
| 04/10/2008 | US20080085291 Solid cosmetic and therapeutic compositions applicable to the human skin and gellable on contact with water |
| 04/10/2008 | US20080085272 Encapsulating therapeutic agent in spider silk fibroin; contolling release of pharmaceutical agents |
| 04/10/2008 | US20080085263 Liquid Depot Formulations |
| 04/10/2008 | US20080085242 modified biodegradable branched chitosans effectively complexed with nucleic acids |
| 04/10/2008 | US20080084000 New type of phase separation of micellar colloid solutions |
| 04/10/2008 | DE102006048130A1 Transdermales therapeutisches System mit zweiphasigem Freisetzungsprofil Transdermal therapeutic system with two-phase release profile |
| 04/10/2008 | DE10066235B4 Targeted inhibition of gene expression by administration of double stranded oligoribonucleotide to a cell, useful for treating humans, animals and plants against viral infection |
| 04/10/2008 | CA2848238A1 Lipid containing formulations |
| 04/10/2008 | CA2665349A1 Particle formation |
| 04/10/2008 | CA2665105A1 Injectable depot composition and its' process of preparation |
| 04/10/2008 | CA2665101A1 Injectable depot composition and it's process of preparation |
| 04/10/2008 | CA2664986A1 Non-mucoadhesive film dosage forms |
| 04/10/2008 | CA2664922A1 Capecitabine pediatric tablets |
| 04/10/2008 | CA2664790A1 Methods and ophthalmic devices used in the treatment of ocular allergies |
| 04/10/2008 | CA2664697A1 Methods, kits, and compositions for generating new hair follicles and growing hair |
| 04/10/2008 | CA2664641A1 Controlled release dosage form of tacrolimus |
| 04/10/2008 | CA2664637A1 Dried reconstituted vesicle formation for pharmaceutical application |
| 04/10/2008 | CA2664615A1 Film embedded packaging and method of making same |
| 04/10/2008 | CA2664158A1 Radiation sensitizer or anti-cancer chemotherapy sensitizer |
| 04/10/2008 | CA2663817A1 Self-preserved aqueous pharmaceutical compositions |
| 04/09/2008 | EP1908770A1 Methods for preparing purified lipopeptides |
| 04/09/2008 | EP1908511A1 Granule dispersion composition, process for producing the same, and granular material and medicine |
| 04/09/2008 | EP1908490A1 Biodegradable, anionic polymers derived from the aminoacid l-tyrosine |
| 04/09/2008 | EP1908482A1 Stabilizer for protein preparation comprising meglumine and use thereof |
| 04/09/2008 | EP1908478A1 Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation |
| 04/09/2008 | EP1908468A1 Aerosol formula for inhalation containing an anticholinergic agent |
| 04/09/2008 | EP1908457A1 Composition based on salts of hyaluronic acid for treating epithelial lesions |
| 04/09/2008 | EP1908449A1 Sterilizer selective to cariogenic bacterium, and method for sterilization of cariogenic bacterium |
| 04/09/2008 | EP1908448A1 Improvements in powder compaction and enrobing |
| 04/09/2008 | EP1908447A2 Improvements in powder compaction and enrobing |
| 04/09/2008 | EP1908446A1 Improvements in powder compaction and enrobing |
| 04/09/2008 | EP1908445A1 Improvements in powder compaction and enrobing |
| 04/09/2008 | EP1908444A1 Improvements in powder compaction and enrobing |
| 04/09/2008 | EP1907022A2 Compositions for topical enzymatic debridement |
| 04/09/2008 | EP1906994A2 Airway administration of activated protein c in inflammatory conditions affecting the respiratory tract |
| 04/09/2008 | EP1906986A1 Lkktet and/or lkktnt peptide compositions which are lyophilized or in a form capable of being lyophilized |
| 04/09/2008 | EP1906981A1 Extracts of ginkgo biloba |
| 04/09/2008 | EP1906976A2 Therapeutic polymers and methods of use |
| 04/09/2008 | EP1906973A2 Pharmaceutical formulations for minimizing drug-drug interactions |
| 04/09/2008 | EP1906968A2 New regimens for oral monophasic contraceptives |
| 04/09/2008 | EP1906963A2 Method of treating ischemia-reperfusion injury |
| 04/09/2008 | EP1906961A2 Solid dosage formulations of narcotic drugs having improved buccal adsorption |
| 04/09/2008 | EP1906949A1 Use of l-carnitine or of alkanoyl l-carnitines for the preparation of a physiological supplement or medicament for ophthalmic use in the form of eye-drops |
| 04/09/2008 | EP1906943A1 Transdermal patch comprising paroxetine |
| 04/09/2008 | EP1906942A2 Polymer film for transdermal patches containing a pharmaceutical active agent |
| 04/09/2008 | EP1906941A2 Methods for treatment of wounds using time release compositions |
| 04/09/2008 | EP1906940A2 Encapsulation of lipid-based formulations in enteric polymers |
| 04/09/2008 | EP1906939A2 Use of a partially neutralized, anionic (meth)acrylate copolymer as a coating for the production of a medicament releasing active substance at reduced ph values |
| 04/09/2008 | EP1906938A2 Pharmaceutical formulation of nitrooxyderivatives of nsaids |
| 04/09/2008 | EP1906937A2 Novel dispersible tablet composition |
| 04/09/2008 | EP1906936A2 Formulations containing losartan and/or its salts |
| 04/09/2008 | EP1906935A2 Extended release venlafaxine compositions |
| 04/09/2008 | EP1906933A2 Novel pharmaceutical modified release dosage form cyclooxygenase enzyme inhibitor |
| 04/09/2008 | EP1906932A2 Modified release pharmaceutical compositions on the basis of two polymers and processes thereof |
| 04/09/2008 | EP1906931A1 Improved pharmaceutical composition containing ace inhibitor and method for the preparation thereof |
| 04/09/2008 | EP1906930A2 Compositions for oral administration of sustained release glutathione, methods for their production and uses thereof |
| 04/09/2008 | EP1906929A2 Biodegradable peptide sustained release compositions containing porogens |
| 04/09/2008 | EP1906928A2 Cores and microcapsules suitable for parenteral administration as well as process for their manufacture |
| 04/09/2008 | EP1906927A1 Composition containing micronutrients with improved anti-oxidant activity and the use thereof. |
| 04/09/2008 | EP1906926A1 Pharmaceutical composition comprising 2 , 3-dihydro-6-nitroimidazo ý2 , 1-b¨oxazole derivatives |
| 04/09/2008 | EP1906925A1 Gelled donepezil compositions and methods for making and using the same |
| 04/09/2008 | EP1906924A1 Bone marrow-directing drug delivery materials and their applications |
| 04/09/2008 | EP1906923A2 Systems and methods for delivery of a therapeutic agent |
| 04/09/2008 | EP1906922A2 Formulations for alteration of biophysical properties of mucosal lining |
| 04/09/2008 | EP1906921A1 Clear pharmaceutical aqueous microemulsion comprising propofuol and process for preparation |
| 04/09/2008 | EP1906920A2 Pharmaceutical composition for treating xerostomia |
| 04/09/2008 | EP1906919A2 Multiple active pharmaceutical ingredients combined in discrete inhalation particles and formulations thereof |
| 04/09/2008 | EP1906918A2 Treatment of conditions associated with the presence of macromolecular aggregates, particularly ophthalmic disorders |
| 04/09/2008 | EP1906917A2 Oral, quickly disintegrating film, which cannot be spit out, for an antiemetic or antimigraine agent |
| 04/09/2008 | EP1906916A2 Ophthalmic suspension comprising an ophthalmic drug, a poloxamine and a glycol tonicity-adjusting agent, use of said composition for the manufacture of a medicament for treating ophthalmic disorders |
| 04/09/2008 | EP1906915A1 Particles having hydrophobic material therein |
| 04/09/2008 | EP1906911A1 Particles comprising a releasable dopant therein |
| 04/09/2008 | EP1906896A2 Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from chitosan and including a polymer mesh material of poly-4-hydroxy butyrate |
| 04/09/2008 | EP1906875A2 Biodegradable self-inflating intragastric implants and method of curbing appetite by the same |
| 04/09/2008 | EP1906846A2 Permeant delivery system and methods for use thereof |
| 04/09/2008 | EP1906760A2 Process |
| 04/09/2008 | EP1906748A2 A delivery system for active components as part of an edible composition including a ratio of encapsulating material and active component |
| 04/09/2008 | EP1677761B1 Suspension of loteprednol etabonate and tobramycin for topical ophthalmic use |
| 04/09/2008 | EP1656099B1 Emulsions with a concentrated internal oil phase |
| 04/09/2008 | EP1553910B1 A capsule filling machine |
| 04/09/2008 | EP1513889B1 Hydrous gel and production process and use of the hydrous gel |
| 04/09/2008 | EP1476489B1 Hydrolytically degradable alkylene oxide based polymers |
| 04/09/2008 | EP1474171B1 Weight management system for obese animals |
| 04/09/2008 | EP1370247B1 Taste masked pharmaceutical compositions |
| 04/09/2008 | EP1345613B1 Probiotic compounds derived from lactobacillus casei strain ke01 |
| 04/09/2008 | EP1343596B1 Surface modification process |
| 04/09/2008 | EP1299348B1 Compounds and compositions for delivering active agents |
| 04/09/2008 | EP1276467B1 Guaifenesin sustained release formulation and tablets |
| 04/09/2008 | EP1135106B1 Sustained release matrix systems for highly soluble drugs |
| 04/09/2008 | EP1124551B1 Delta 9 tetrahydrocannabinol (delta 9 thc) solution metered dose inhalers and methods of use |
| 04/09/2008 | EP1100892B1 Use of prohibitin rna in treatment of cancer |
| 04/09/2008 | EP0991371B1 A method for treating dentures |